Stein-Gold, L., B. Elewski, Z. Draelos, and T. Lin. “Safety and Efficacy of a Fixed Combination Halobetasol Propionate 0.01%/Tazarotene 0.045% (HP/TAZ) Lotion in the Treatment of Females With Moderate-to-Severe Plaque Psoriasis”. SKIN The Journal of Cutaneous Medicine, vol. 4, no. 1, Jan. 2020, p. S9, https://jofskin.org/33014/index.php/skin/article/view/822.